$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the life expectancy after treatment with dasatinib?
2026-02-01 22:25:32
Check Details
Are there any contraindications for dasatinib?
2026-02-01 22:25:32
Check Details
When should discontinuation of brigatinib be considered?
2026-02-01 22:25:32
Check Details
Detailed explanation of the duration and dosage of brigatinib
2026-02-01 22:25:32
Check Details
Brigatinib (Brigatinib) generic drug price revealed: How much does the Laos Lucius version cost?
2026-02-01 22:25:32
Check Details
Detailed explanation of brigatinib purchase price and channels
2026-02-01 22:25:32
Check Details
Does brigatinib require long-term and lifelong medication?
2026-02-01 22:25:32
Check Details
Is Mobotinib (Mobosetinib) available in China?
2026-02-01 22:25:32
Check Details
How much is the latest price of Mobotinib (Mobosetinib) per box in 2024?
2026-02-01 22:25:32
Check Details
Mobotinib (mobosetinib) enters medical insurance time
2026-02-01 22:25:32
Check Details
Which generation of targeted drugs does Mobotinib belong to?
2026-02-01 22:25:32
Check Details
How effective is erdafitinib in treating pancreatic cancer?
2026-02-01 22:25:32
Check Details
1
2
...
944
945
946
947
948
949
950
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
2
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
3
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
4
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
5
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
6
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
7
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
8
Elagolix Side Effects and Safety Guide
9
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
10
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
11
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
12
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA